ZA200508178B - A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists - Google Patents
A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonistsInfo
- Publication number
- ZA200508178B ZA200508178B ZA200508178A ZA200508178A ZA200508178B ZA 200508178 B ZA200508178 B ZA 200508178B ZA 200508178 A ZA200508178 A ZA 200508178A ZA 200508178 A ZA200508178 A ZA 200508178A ZA 200508178 B ZA200508178 B ZA 200508178B
- Authority
- ZA
- South Africa
- Prior art keywords
- humans
- prevention
- growth factor
- hepatocyte growth
- malaria infection
- Prior art date
Links
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 title 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45348303P | 2003-03-12 | 2003-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200508178B true ZA200508178B (en) | 2007-04-25 |
Family
ID=32990777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200508178A ZA200508178B (en) | 2003-03-12 | 2005-10-10 | A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
Country Status (8)
Country | Link |
---|---|
US (1) | US7670631B2 (ja) |
EP (1) | EP1601378A2 (ja) |
JP (1) | JP2007525428A (ja) |
CN (1) | CN1809382A (ja) |
AP (1) | AP2005003411A0 (ja) |
BR (1) | BRPI0408268A (ja) |
WO (1) | WO2004080420A2 (ja) |
ZA (1) | ZA200508178B (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7968605B2 (en) | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
WO2003066067A2 (en) | 2002-02-04 | 2003-08-14 | Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
GB2395432B (en) | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
CN1255106C (zh) * | 2003-09-26 | 2006-05-10 | 李国桥 | 复方青蒿素 |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
US7566465B2 (en) * | 2006-12-21 | 2009-07-28 | The United States Of America As Represented By The Secretary Of The Army | Artemisinins in the clinical and veterinary management of kinetoplastid infections |
WO2008147826A1 (en) * | 2007-05-22 | 2008-12-04 | Seattle Biomedical Research Institute | Malaria liver stage drugs |
CA2714121C (en) | 2008-02-05 | 2016-03-22 | Forskarpatent I Syd Ab | Selection of rna-aptamers as anti-malaria agents |
US20110092452A1 (en) * | 2008-03-05 | 2011-04-21 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating pancreatic cancer |
EP2470013A4 (en) | 2009-08-27 | 2013-05-01 | Us Health | COMPOUNDS FOR THE TREATMENT OF MALARIA AND FOR PREVENTING MALARIA TRANSMISSIONS |
FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
CA2782236A1 (en) * | 2009-12-15 | 2011-06-23 | Dec International Nz Limited | Treatment composition and method |
KR20130028058A (ko) * | 2010-02-03 | 2013-03-18 | 엠이에이치 어소시에이츠, 인코포레이티드 | 선택적 및 생활성 동배체로서의 다수 치환된 플루오로메탄류 |
EP2404601A1 (en) * | 2010-07-06 | 2012-01-11 | BioAgency AG | New drug combinations for the treatment of Malaria |
WO2012135064A2 (en) * | 2011-03-25 | 2012-10-04 | The Regents Of The University Of California | Attenuated strains of plasmodium |
US9163044B2 (en) | 2011-04-19 | 2015-10-20 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドAlfama,Inc. | 一酸化ルテニウム放出分子およびその使用 |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
US20160151380A1 (en) * | 2013-07-12 | 2016-06-02 | The Regents Of The University Of California | Therapies for diseases caused by arthropod-borne parasites |
WO2015178940A1 (en) * | 2014-05-20 | 2015-11-26 | American University Of Cairo (Auc) | Ligands that target plasmodium sporozoite binding sites on cd81 and therapeutic methods using them |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344321B1 (en) | 1990-06-11 | 2002-02-05 | Gilead Sciences, Inc. | Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
US6887499B2 (en) * | 2000-05-22 | 2005-05-03 | Enitan A. Bababunmi | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
-
2004
- 2004-03-09 US US10/795,456 patent/US7670631B2/en not_active Expired - Fee Related
- 2004-03-11 BR BRPI0408268-0A patent/BRPI0408268A/pt not_active IP Right Cessation
- 2004-03-11 WO PCT/US2004/007516 patent/WO2004080420A2/en active Application Filing
- 2004-03-11 CN CNA2004800119782A patent/CN1809382A/zh active Pending
- 2004-03-11 AP AP2005003411A patent/AP2005003411A0/xx unknown
- 2004-03-11 EP EP04719810A patent/EP1601378A2/en not_active Withdrawn
- 2004-03-11 JP JP2006507105A patent/JP2007525428A/ja active Pending
-
2005
- 2005-10-10 ZA ZA200508178A patent/ZA200508178B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1809382A (zh) | 2006-07-26 |
BRPI0408268A (pt) | 2006-03-07 |
WO2004080420A2 (en) | 2004-09-23 |
US7670631B2 (en) | 2010-03-02 |
AP2005003411A0 (en) | 2005-12-31 |
JP2007525428A (ja) | 2007-09-06 |
US20040185050A1 (en) | 2004-09-23 |
EP1601378A2 (en) | 2005-12-07 |
WO2004080420A3 (en) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200508178B (en) | A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists | |
IL171145A (en) | Method for the production of telmisartan | |
HK1072961A1 (en) | A method of forming a nanocomposite coating. | |
EP1569515A4 (en) | MALARIA vaccine method | |
IL175148A0 (en) | Method for the production of fluoromethyl-substituted heterocycles | |
HK1078802A1 (en) | Increasing the bioavailability of alendronate by predose administration alphacalcidol | |
IL180893A (en) | Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative | |
PL375558A1 (en) | A method of extending the dose range of vitamin d compounds | |
PT1753393T (pt) | Procedimento de inoformulação de uma base galénica biocompatível | |
PL3001906T3 (pl) | Sposób zapobiegania lub zwalczania zakażenia grzybami | |
AU2003299284A8 (en) | Method for the production of a semiconductor component | |
HK1096398A1 (en) | Method for the manufacture of thip thip | |
HK1075936A1 (en) | Vaccine for the prevention of malaria | |
FI20021968A0 (fi) | Menetelmä hiivojen kasvun estämiseksi | |
IL182395A0 (en) | A method of forming a desiccating part | |
AU2003297044A8 (en) | Method of forming sub-micron-size structures over a substrate | |
EP1556400A4 (en) | PROCESS FOR THE PREPARATION OF 2-HALOGEN-2-DESOXYADENOSINE COMPOUNDS FROM 2-DESOXYGUANOSINE | |
ITUD20040054A1 (it) | Procedimento per la realizzazione di un | |
ITBO20020602A1 (it) | Apparecchiatura per la realizzazione di decori artistici, | |
EP1676578A4 (en) | METHOD FOR STABILIZING DIARYLVINYLENE COMPOUND | |
IL174980A0 (en) | Process for the preparation of a trifluoromethylthioether | |
ITBZ20030031A1 (it) | Procedimento per la preparazione di un substrato | |
AU2003296459A1 (en) | A set of building components for building a plurality of predefined structures | |
ITBO20010166A0 (it) | Apparecchiatura per la movimentazione automatica di ante a battente | |
ITBO20020697A1 (it) | Gruppo per la movimentazione verticale di strutture |